InvestorsHub Logo

gator16

04/30/14 7:24 AM

#3291 RE: Ned Serious #3290

From IV Board
Results for Trimesta are POSITIVE, folks <EOM>


on the company website with today's announcement you see that at 24 months estriol arm Persists meaning that the 47 percent is maintained in year 2 versus 30 percent for copaxone alone.

Not trying to twist but have read the year two statement and 47 to 30 would not be any example of the word resistance